294 related articles for article (PubMed ID: 11877480)
1. Structure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivity.
Hennecke J; Wiley DC
J Exp Med; 2002 Mar; 195(5):571-81. PubMed ID: 11877480
[TBL] [Abstract][Full Text] [Related]
2. Minimal conformational plasticity enables TCR cross-reactivity to different MHC class II heterodimers.
Holland CJ; Rizkallah PJ; Vollers S; Calvo-Calle JM; Madura F; Fuller A; Sewell AK; Stern LJ; Godkin A; Cole DK
Sci Rep; 2012; 2():629. PubMed ID: 22953050
[TBL] [Abstract][Full Text] [Related]
3. Structure of a covalently stabilized complex of a human alphabeta T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1.
Hennecke J; Carfi A; Wiley DC
EMBO J; 2000 Nov; 19(21):5611-24. PubMed ID: 11060013
[TBL] [Abstract][Full Text] [Related]
4. Contribution of T-cell receptor-contacting and peptide-binding residues of the class II molecule HLA-DR4 Dw10 to serologic and antigen-specific T-cell recognition.
Barber LD; Bal V; Lamb JR; O'Hehir RE; Yendle J; Hancock RJ; Lechler RI
Hum Immunol; 1991 Oct; 32(2):110-8. PubMed ID: 1744001
[TBL] [Abstract][Full Text] [Related]
5. Molecular mimicry by major histocompatibility complex molecules and peptides accounts for some alloresponses.
Lechler RI; Heaton T; Barber L; Bal V; Batchelor JR; Lombardi G
Immunol Lett; 1992 Sep; 34(1):63-9. PubMed ID: 1478706
[TBL] [Abstract][Full Text] [Related]
6. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen.
Rosloniec EF; Whittington KB; Zaller DM; Kang AH
J Immunol; 2002 Jan; 168(1):253-9. PubMed ID: 11751969
[TBL] [Abstract][Full Text] [Related]
7. [The inhibitory effect of hyporesponsive peptide on human leukocyte antigen-DRbeta1 specific T cell activation].
Zhou Q; Cheng YJ; Li ZG; Zhou WH; Lu HS
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1505-9. PubMed ID: 14521731
[TBL] [Abstract][Full Text] [Related]
8. Association of HLA-DR1 with the allergic response to the major mugwort pollen allergen: molecular background.
Knapp B; Fischer G; Van Hemelen D; Fae I; Maillere B; Ebner C; Schreiner W; Bohle B; Jahn-Schmid B
BMC Immunol; 2012 Aug; 13():43. PubMed ID: 22871092
[TBL] [Abstract][Full Text] [Related]
9. Peptide-MHC Binding Reveals Conserved Allosteric Sites in MHC Class I- and Class II-Restricted T Cell Receptors (TCRs).
He Y; Agnihotri P; Rangarajan S; Chen Y; Kerzic MC; Ma B; Nussinov R; Mariuzza RA; Orban J
J Mol Biol; 2020 Dec; 432(24):166697. PubMed ID: 33157083
[TBL] [Abstract][Full Text] [Related]
10. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
11. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.
Busch R; Hill CM; Hayball JD; Lamb JR; Rothbard JB
J Immunol; 1991 Aug; 147(4):1292-8. PubMed ID: 1869824
[TBL] [Abstract][Full Text] [Related]
12. Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401).
Rosloniec EF; Whittington KB; He X; Stuart JM; Kang AH
Am J Med Sci; 2004 Apr; 327(4):169-79. PubMed ID: 15084912
[TBL] [Abstract][Full Text] [Related]
13. T cell receptors recognizing type II collagen in HLA-DR-transgenic mice characterized by highly restricted V beta usage.
He X; Rosloniec EF; Myers LK; McColgan WL; Gumanovskaya M; Kang AH; Stuart JM
Arthritis Rheum; 2004 Jun; 50(6):1996-2004. PubMed ID: 15188377
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects on HLA-DR1-specific T-cell activation by influenza virus haemagglutinin-derived peptides.
Li X; Li R; Li Z
Tissue Antigens; 2006 Jan; 67(1):45-52. PubMed ID: 16451200
[TBL] [Abstract][Full Text] [Related]
15. Mapping T cell recognition: the identification of a T cell receptor residue critical to the specific interaction with an influenza hemagglutinin peptide.
Wedderburn LR; Searle SJ; Rees AR; Lamb JR; Owen MJ
Eur J Immunol; 1995 Jun; 25(6):1654-62. PubMed ID: 7614994
[TBL] [Abstract][Full Text] [Related]
16. Evidence for preferred MHC class II-TCR recognition independent of the source of bound peptide.
Battaglia M; Gorski J
Eur J Immunol; 2002 Aug; 32(8):2179-87. PubMed ID: 12209630
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte responses to DR1/4 restricted peptides in rheumatoid arthritis.
Skinner MA; Watson L; Geursen A; Tan PL
Ann Rheum Dis; 1994 Mar; 53(3):171-7. PubMed ID: 8154934
[TBL] [Abstract][Full Text] [Related]
18. Identification of T cell ligands in a library of peptides covalently attached to HLA-DR4.
Boen E; Crownover AR; McIlhaney M; Korman AJ; Bill J
J Immunol; 2000 Aug; 165(4):2040-7. PubMed ID: 10925287
[TBL] [Abstract][Full Text] [Related]
19. Evidences of conformational changes in class II Major Histocompatibility Complex molecules that affect the immunogenicity.
Neveu R; Auriault C; Angyalosi G; Georges B
Mol Immunol; 2002 Feb; 38(9):661-7. PubMed ID: 11858821
[TBL] [Abstract][Full Text] [Related]
20. Modeling the interactions of a peptide-major histocompatibility class I ligand with its receptors. II. Cross-reaction between a monoclonal antibody and two alpha beta T cell receptors.
Rognan D; Engberg J; Stryhn A; Andersen PS; Buus S
J Comput Aided Mol Des; 2000 Jan; 14(1):71-82. PubMed ID: 10702926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
